This speculative review of potential medical applications of LLMs completely ignores two of the largest risks - model hallucinations and premature clinical deployment by credulous hospital administrators of unverified and unverifiable systems trained on proprietary datasets by unscrupulous vendors.


Even more troubling is the fact that Eric Topol, one of the corresponding authors on the paper, didn't declare any competing interests for the paper when he's a scientific advisor for a AI based precision medicine company.

Sign in to participate in the conversation
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.